|
Mutation Information
|
Mutation Site
|
A181V |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Genotype/Subtype
|
B;C |
|
Relevant Drug
|
adefovir (ADV);adefovir dipivoxil (ADV) |
|
Country
|
China |
Literature Information
|
PubMed PMID
|
25132017
|
|
Disease
|
HBV infection
|
|
Published Year
|
2015 |
|
Journal
|
Journal of viral hepatitis |
|
Title
|
The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxil. |
|
Author
|
Liu Y,Li X,Xin S,Xu Z,Chen R,Yang J,Liu L,Wong VW,Yang D,Chan HL,Xu D |
|
Evidence
|
Phenotypic analysis of patient-derived viral strains showed that rtA181S, rtA181S+N236T, rtN236T and rtA181V strains had 68.5%, 49.9%, 71.4% and 66.2% of natural replication capacity of wild-type strain, and 3.7-fold, 9.8-fold, 7.9-fold and 5.6-fold increased EC(50) to adefovir dipivoxil (ADV).
|
|
|
HBV Mutation Detail Information